WR
ABBV icon

WD Rutherford’s AbbVie ABBV Stock Holding History

WD Rutherford’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,958
Closed -$803K – 72
2023
Q2 		$803K Hold
5,958
– – 0.51% 48
2023
Q1 		$950K Hold
5,958
– – 0.67% 42
2022
Q4 		$963K Hold
5,958
– – 0.76% 42
2022
Q3 		$800K Buy
5,958
+4,785
+408% +$687K 0.64% 46
2022
Q2 		$180K Buy
1,173
+45
+4% +$6.88K 0.14% 70
2022
Q1 		$183K Sell
1,128
-45
-4% -$6.54K 0.1% 78
2021
Q4 		$159K Hold
1,173
– – 0.08% 81
2021
Q3 		$127K Hold
1,173
– – 0.07% 86
2021
Q2 		$132K Hold
1,173
– – 0.07% 84
2021
Q1 		$127K Buy
1,173
+60
+5% +$6.42K 0.08% 84
2020
Q4 		$119K Buy
+1,113
New +$107K 0.08% 80

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WD Rutherford's ABBV Position: Q3 2023 in Review

WD Rutherford sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 5,958 shares — an estimated $803K sold.

WD Rutherford first reported a position in ABBV in Q4 2020 and held it in 11 quarters. The position peaked at $963K in Q4 2022. 3,109 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • WD Rutherford reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • WD Rutherford sold 5,958 AbbVie shares in Q3 2023, an estimated $803K.
  • WD Rutherford first reported a position in AbbVie in Q4 2020 and held it in 11 quarters.
  • WD Rutherford's AbbVie position peaked at $963K in Q4 2022.
  • 3,109 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on WD Rutherford's 13F filing for Q3 2023, filed 24 Oct 2023.